Skip to main content

Table 1 Subject demographics

From: Vaccination response to tetanus toxoid and 23-valent pneumococcal vaccines following administration of a single dose of abatacept: a randomized, open-label, parallel group study in healthy subjects

Characteristic

Group A (vaccines alone on day 1) (n = 20)

Group B (vaccines 2 weeks before abatacept) (n = 20)

Group C (vaccines 2 weeks after abatacept) (n = 20)

Group D (vaccines 8 weeks after abatacept) (n = 20)

Age (years)

    

   Mean

34

34

34

36

   Standard deviation

12

13

11

13

   Range

18–55

18–56

19–56

20–56

Gender (n (%))

    

   Male

10 (50)

8 (40)

10 (50)

11 (55)

   Female

10 (50)

12 (60)

10 (50)

9 (45)

Race (n (%))

    

   White

15 (75)

12 (60)

14 (70)

11 (55)

   Black

5 (25)

8 (40)

6 (30)

8 (40)

   Other

0

0

0

1 (5)